Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
17 studies found for:    "Oral leukoplakia"
Show Display Options
Rank Status Study
1 Terminated A Phase II Trial to Assess the Effects of Green Tea in Oral Leukoplakia
Condition: Oral Leukoplakia
Intervention: Drug: Lozenge Intake
2 Completed Photodynamic Therapy for Oral Leukoplakia and Erythroleukoplakia
Condition: Oral Leukoplakia
Intervention: Procedure: photodynamic therapy
3 Completed Rosiglitazone Maleate in Treating Patients With Oral Leukoplakia
Condition: Oral Leukoplakia
Interventions: Drug: rosiglitazone maleate;   Other: laboratory biomarker analysis
4 Completed
Has Results
Bowman-Birk Inhibitor Concentrate in Preventing Cancer in Patients With Oral Leukoplakia
Conditions: Lip and Oral Cavity Cancer;   Oral Leukoplakia;   Oropharyngeal Cancer;   Tongue Cancer
Interventions: Drug: Bowman-Birk inhibitor concentrate;   Other: placebo;   Other: laboratory biomarker analysis
5 Completed
Has Results
Pioglitazone Hydrochloride in Preventing Head and Neck Cancer in Patients With Oral Leukoplakia
Conditions: Head and Neck Cancer;   Oral Leukoplakia
Intervention: Drug: pioglitazone hydrochloride
6 Terminated Photodynamic Therapy Using Aminolevulinic Acid in Treating Patients With Oral Leukoplakia
Condition: Oral Leukoplakia
Interventions: Drug: aminolevulinic acid hydrochloride;   Drug: photodynamic therapy;   Other: laboratory biomarker analysis
7 Completed Celecoxib in Preventing Head and Neck Cancer in Patients With Oral Leukoplakia
Conditions: Head and Neck Cancer;   Precancerous Condition
Intervention: Drug: celecoxib
8 Recruiting Metformin Hydrochloride in Preventing Oral Cancer in Patients With an Oral Premalignant Lesion
Conditions: Erythroplakia;   Hyperplasia;   Mild Dysplasia;   Moderate Dysplasia;   Oral Cavity Carcinoma;   Oral Leukoplakia;   Severe Dysplasia
Interventions: Other: Laboratory Biomarker Analysis;   Drug: Metformin Hydrochloride
9 Terminated
Has Results
Pioglitazone for Oral Premalignant Lesions
Condition: Oral Leukoplakia
Interventions: Drug: Pioglitazone hydrochloride;   Other: placebo;   Other: laboratory biomarker analysis
10 Unknown  Least Invasive Nonlinear Light Microscopy
Conditions: Oral Leukoplakia;   Oral Cancer
Intervention:
11 Completed Biomarkers for Oral Cancer
Conditions: Lichen Planus;   Oral Leukoplakia
Intervention:
12 Completed Fenretinide in Treating Patients With Leukoplakia of the Mouth
Condition: Head and Neck Cancer
Interventions: Drug: fenretinide;   Drug: Placebo
13 Completed Aspirin Mouthwash in Treating Patients With Oral Leukoplakia
Condition: Precancerous Condition
Interventions: Drug: acetylsalicylic acid;   Genetic: gene expression analysis;   Genetic: protein expression analysis;   Other: laboratory biomarker analysis;   Other: questionnaire administration;   Procedure: biopsy
14 Unknown  Infectious Aetiology of Potentially Malignant Disorders and Squamous Cell Carcinomas of the Oral Cavity
Conditions: Squamous Cell Carcinoma of the Oral Cavity;   Leukoplakia Oral
Intervention: Procedure: contralateral healthy tissue biopsy
15 Unknown  Celecoxib in Preventing Cancer in Patients With Oral Leukoplakia and/or Head and Neck Dysplasia
Condition: Head and Neck Cancer
Intervention: Drug: celecoxib
16 Completed
Has Results
Photodynamic Therapy With Porfimer Sodium in Treating Patients With Precancerous Lesions, Cancer, or Other Disease of the Aerodigestive Tract
Conditions: Head and Neck Cancer;   Precancerous/Nonmalignant Condition
Interventions: Drug: Porfimer Sodium;   Procedure: Photodynamic Therapy
17 Active, not recruiting A Randomized Study of Sulindac in Oral Premalignant Lesions
Conditions: Leukoplakia, Oral;   Benign Neoplasms
Interventions: Drug: sulindac;   Drug: Placebo

Indicates status has not been verified in more than two years